Cardiol Therapeutics Inc. (CRDL)

NASDAQ: CRDL · Real-Time Price · USD

1.170

-0.030 (-2.50%)

Jul 29, 2026, 10:14 AM EDT - Market open

Cardiol Therapeutics Balance Sheet

Financials in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	27.67	21.42	30.58	34.93	59.47	83.9
Cash & Short-Term Investments	27.67	21.42	30.58	34.93	59.47	83.9
Cash Growth	18.81%	-29.97%	-12.46%	-41.26%	-29.12%	498.20%
Accounts Receivable	0.07	0.06	0.1	0.14	0.21	0.07
Other Receivables	0.27	0.17	0.26	0.14	0.27	0.34
Total Trade Receivables	0.34	0.23	0.36	0.28	0.48	0.41
Other Current Assets	3.25	1.86	0.73	0.94	1.49	2.83
Total Current Assets	31.27	23.5	31.67	36.15	61.44	87.14
Net Property, Plant & Equipment	0.14	0.12	0.2	0.34	0.3	0.36
Other Intangible Assets	-	-	-	0.21	0.29	0.38
Total Assets	31.41	23.62	31.86	36.7	62.03	87.88

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	3.42	3.48	6.98	8.04	9.33	4.86
Current Portion of Leases	0.04	0.04	0.03	0.02	0.05	0.04
Other Current Liabilities	3.67	2.14	-	0.24	0.42	6.66
Total Current Liabilities	7.13	5.66	7.01	8.3	9.8	11.57
Long-Term Leases	0.08	0.09	0.13	0.16	0.02	0.07
Total Long-Term Liabilities	0.08	0.09	0.13	0.16	0.02	0.07
Total Liabilities	7.2	5.74	7.14	8.45	9.83	11.64

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	212.8	201.87	179.34	148.52	147.55	142.92
Additional Paid-in Capital	35.29	29.08	24.65	22.3	19.1	16.84
Retained Earnings	-223.89	-213.07	-179.25	-142.58	-114.45	-83.52
Shareholders' Equity	24.2	17.88	24.73	28.25	52.2	76.24
Total Liabilities & Equity	31.41	23.62	31.86	36.7	62.03	87.88

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	0.12	0.13	0.16	0.17	0.07	0.12
Net Cash (Debt)	27.56	21.29	30.42	34.76	59.4	83.78
Net Cash Growth	19.08%	-30.01%	-12.47%	-41.48%	-29.10%	504.11%
Net Cash Per Share	0.29	0.24	0.42	0.54	0.95	1.94
Book Value	24.2	17.88	24.73	28.25	52.2	76.24
Book Value Per Share	0.26	0.21	0.35	0.44	0.84	1.76
Tangible Book Value	24.2	17.88	24.73	28.04	51.91	75.86
Tangible Book Value Per Share	0.26	0.21	0.35	0.43	0.83	1.76

SEC Filings: 10-K · 10-Q